Circulating microRNAs in breast cancer and healthy subjects

被引：275

作者：

Zhu W. ^{[1
]}

Qin W. ^{[1
]}

Atasoy U. ^{[2
]}

Sauter E.R. ^{[1
]}

机构：

[1] Department of Surgery, University of North Dakota, Grand Forks, ND

[2] Department of Surgery, University of Missouri, Columbia, MO

来源：

BMC Research Notes | / 2卷 / 1期

关键词：

Breast Cancer; Serum Specimen; Breast Cancer Detection; Human Serum Sample; miRNA Signature;

D O I：

10.1186/1756-0500-2-89

中图分类号：

学科分类号：

摘要：

Background. It has been demonstrated that extracellular mRNA can be detected in the circulation. Our hypothesis was that circulating miRNAs are also present and differentially expressed in the serum of breast cancer patients compared to controls. Findings. We measured miRNA in the serum of samples with and without the addition of miRNA prior to analysis. To test our RNA extraction efficiency, we spiked-in serial dilutions of single-strand C elegens miR-39 (cel-miR-39) and human miR-145 (has-miR-145) into goat serum and a 10 year old human serum specimen. We next analyzed miR-16, -145, and -155 in archived serum specimens from 21 participants, 13 of whom did and 8 of whom did not have breast cancer. We were able to detect the miRNAs from all the serum samples to which the miRNAs had been added. We were also able to detect endogenous miR-16, -145, and -155 in all serum samples. While the expression of all three miRNAs was similar in samples from healthy women compared to those with breast cancer, women with progesterone receptor (PR, p = 0.016) positive tumors had higher miR-155 expression than tumors that were negative for these receptors. Conclusion. 1) RNA species can be detected in archived serum; 2) miR-155 may be differentially expressed in the serum of women with hormone sensitive compared to women with hormone insensitive breast cancer. Screening serum for miRNAs that predict the presence of breast cancer is feasible, and may be useful for breast cancer detection. © 2009 Sauter et al; licensee BioMed Central Ltd.

引用

共 22 条

[1]

Calin G.A., Croce C.M., MicroRNA signatures in human cancers, Nat Rev Cancer, 6, 11, pp. 857-866, (2006)

[2]

Calin G.A., Croce C.M., MicroRNA-cancer connection: The beginning of a new tale, Cancer Research, 66, 15, pp. 7390-7394, (2006)

[3]

Jeyaseelan K., Herath W.B., Armugam A., MicroRNAs as therapeutic targets in human diseases, Expert Opin Ther Targets, 11, 8, pp. 1119-1129, (2007)

[4]

Kim J., Krichevsky A., Grad Y., Hayes G.D., Kosik K.S., Church G.M., Ruvkun G., Identification of many microRNAs that copurify with polyribosomes in mammalian neurons, Proceedings of the National Academy of Sciences of the United States of America, 101, 1, pp. 360-365, (2004)

[5]

Esquela-Kerscher A., Slack F.J., Oncomirs - MicroRNAs with a role in cancer, Nat Rev Cancer, 6, 4, pp. 259-269, (2006)

[6]

Iorio M.V., Ferracin M., Liu C.G., Veronese A., Spizzo R., Sabbioni S., Magri E., Pedriali M., Fabbri M., Campiglio M., Et al., MicroRNA gene expression deregulation in human breast cancer, Cancer Res, 65, 16, pp. 7065-7070, (2005)

[7]

Liang Y., Ridzon D., Wong L., Chen C., Characterization of microRNA expression profiles in normal human tissues, BMC Genomics, 8, (2007)

[8]

Lo K.W., Lo Y.M., Leung S.F., Tsang Y.S., Chan L.Y., Johnson P.J., Hjelm N.M., Lee J.C., Huang D.P., Analysis of cell-free Epstein-Barr virus associated RNA in the plasma of patients with nasopharyngeal carcinoma, Clin Chem, 45, 8 PART 1, pp. 1292-1294, (1999)

[9]

Kopreski M.S., Benko F.A., Kwak L.W., Gocke C.D., Detection of tumor messenger RNA in the serum of patients with malignant melanoma, Clin Cancer Res, 5, 8, pp. 1961-1965, (1999)

[10]

Chen X.Q., Bonnefoi H., Pelte M.F., Lyautey J., Lederrey C., Movarekhi S., Schaeffer P., Mulcahy H.E., Meyer P., Stroun M., Et al., Telomerase RNA as a detection marker in the serum of breast cancer patients, Clin Cancer Res, 6, 10, pp. 3823-3826, (2000)

← 1 2 3 →